⌘K

Login Start Free

Home/Filings/4/0001209191-23-033145

4//SEC Filing

KIDRON NADAV 4

Accession 0001209191-23-033145

CIK 0001176309other

View on SEC.gov Company Profile

Filed

May 30, 8:00 PM ET

Accepted

May 31, 5:10 PM ET

Size

5.6 KB

Accession

0001209191-23-033145

Insider Transaction Report

Form 4

Period: 2023-05-26

ORAMED PHARMACEUTICALS INC.ORMP

DirectorPresident and CEO

Transactions

Award
Common Stock
2023-05-26+120,000→ 1,452,098 total

Holdings

Common Stock
(indirect: By wholly-owned corporation)
126,000

Footnotes (1)

[F1]Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001351779

Filing Metadata

Form type: 4
Filed: May 30, 8:00 PM ET
Accepted: May 31, 5:10 PM ET
Size: 5.6 KB

View on SEC.gov